Reflections On Biotech In 2025: The Spotlight On Tangible Outcomes
Forbes Councils Member.
Mar 31, 2025, 08:00am EDT
AI continued to be a theme at this year’s J.P. Morgan Health Conference and the first quarter of 2025, with Nvidia’s collaborations with Iqvia and Illumina and Amazon Web Services’s partnership with venture capital firm General Catalyst. Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology buzzwords and hype have lost their shine in pharma, and the spotlight is now back on tangible outcomes and the ability to efficiently establish and de-risk late-stage assets.
While technology has accelerated drug discovery, it has also increased the production volume of candidates that have failed validation or proven to be novel. Discovering 100 drugs in two months may sound impressive, but the true test is how many of those progress into meaningful INDs and successful clinical assets.
Full Story: Reflections On Biotech In 2025: The Spotlight On Tangible Outcomes
About BPGbio
BPGbio is a leading biology-first AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in late-stage clinical trials. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform, protected by over 400 US and international patents; one of the world’s largest clinically annotated non-governmental biobanks with longitudinal samples; and exclusive access to the most powerful supercomputer in the world. With these tools, BPGbio is redefining how patient biology can be modeled using bespoke Bayesian AI specifically designed for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease. For more information, visit www.bpgbio.com.
Contact
Media Contact:
media@bpgbio.com
